Surgery Partners, Inc.
SGRY · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3 | $3 | $3 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $4 | $4 | $4 |
| Enterprise Value | $3 | $6 | $7 | $6 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -0.6% | 6.5% | -10.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 23.8% | 23.7% | 20.9% | 27% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 49.3% | 18.4% | 12.7% | 18.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2.8% | -0.3% | -4.9% | -12.6% |
| EPS Diluted | -0.18 | -0.02 | -0.3 | -0.86 |
| % Growth | -813.7% | 93.4% | 65.1% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |